TY  - JOUR

T1  - Dupilumab treatment in children aged 6–11 years with severe atopic dermatitis is associated with reductions in serum immunoglobulin E and thymus and activation-regulated chemokine levels

JO  - Revue Française d'Allergologie

UR  - http://dx.doi.org/10.1016/j.reval.2023.103436

PY  - 2023/04/01

AU  - Cork MJ

AU  - Wollenberg A

AU  - Siegfried EC

AU  - Rossi AB

AU  - Chen Z

AU  - Levit NA

AU  - Marco AR

ED  - 

DO  - DOI: 10.1016/j.reval.2023.103436

PB  - Elsevier BV

VL  - 63

IS  - 3

SP  - 103436

EP  - 103436

Y2  - 2024/12/22

ER  -